The researchers, who analysed the medical data of hundreds of millions of people, warned that cannabis is "getting more ...

MONDAY, June 23, 2025 (HealthDay News) — Weed is associated with a doubled risk of death from heart disease, a new evidence ...

Using marijuana doubles the risk of dying from heart disease, especially from stroke and heart attacks, a large new study ...

JUNE 10, 2025 — UTSA researchers in the Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated ...

Torsades de pointes (TdP) arrhythmia is a potentially life-threatening cardiac disorder that is often associated with a prolonged QT interval in the surface ECG. Many drugs from different chemical ...

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of ...

The Pharmacology and Toxicology Graduate Group is an interdisciplinary program that combines coursework and experimental training in modern approaches to pharmacological and toxicological problems.

A groundbreaking new study suggests that sotagliflozin, a drug recently approved to treat type 2 diabetes and kidney disease in people with additional cardiovascular risk factors, can also ...

The blockbuster diabetes and weight loss drug semaglutide (Wegovy, Ozempic, Rybelsus) reduced the relative risk of heart attack, stroke, or cardiovascular deaths by 20 percent in high-risk ...